China Health Group Limited (HKG:0673)
Hong Kong · Delayed Price · Currency is HKD 0.3400
+0.0100 (3.03%)
Jul 22, 2025, 3:19 PM HKT
China Health Group Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 38.94 | 59.93 | 76.41 | 107.03 | 87.89 | Upgrade | |
Revenue Growth (YoY) | -35.02% | -21.57% | -28.60% | 21.77% | 94.62% | Upgrade |
Cost of Revenue | 29.71 | 46.29 | 49.22 | 78.34 | 61.9 | Upgrade |
Gross Profit | 9.24 | 13.64 | 27.19 | 28.69 | 25.99 | Upgrade |
Selling, General & Admin | 68.83 | 49.75 | 39.99 | 39.22 | 37.28 | Upgrade |
Operating Expenses | 68.83 | 49.75 | 40.02 | 39.99 | 38.17 | Upgrade |
Operating Income | -59.6 | -36.11 | -12.82 | -11.3 | -12.18 | Upgrade |
Interest Expense | -0.25 | -0.33 | -2.19 | -0.29 | -0.29 | Upgrade |
Interest & Investment Income | 0.01 | 0.92 | 0.44 | 0.33 | 5.14 | Upgrade |
Earnings From Equity Investments | - | - | -4 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 16.54 | 18.78 | -3.35 | -1.9 | 1.99 | Upgrade |
EBT Excluding Unusual Items | -43.3 | -16.74 | -21.92 | -13.16 | -5.34 | Upgrade |
Merger & Restructuring Charges | - | -1.33 | - | -0.3 | - | Upgrade |
Impairment of Goodwill | -11.75 | -13.83 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 3.31 | -0.23 | - | 0.01 | Upgrade |
Asset Writedown | -17.64 | - | - | - | - | Upgrade |
Other Unusual Items | 5.31 | -13.7 | -17.23 | 4.75 | - | Upgrade |
Pretax Income | -67.38 | -42.29 | -39.38 | -8.71 | -5.33 | Upgrade |
Income Tax Expense | 0.44 | 0.2 | 0.18 | 0.41 | 1.23 | Upgrade |
Earnings From Continuing Operations | -67.82 | -42.5 | -39.56 | -9.11 | -6.56 | Upgrade |
Minority Interest in Earnings | 0.03 | 2.31 | -2.49 | -3.09 | -1.19 | Upgrade |
Net Income | -67.79 | -40.19 | -42.05 | -12.21 | -7.74 | Upgrade |
Net Income to Common | -67.79 | -40.19 | -42.05 | -12.21 | -7.74 | Upgrade |
Shares Outstanding (Basic) | 487 | 475 | 427 | 412 | 412 | Upgrade |
Shares Outstanding (Diluted) | 487 | 475 | 427 | 412 | 412 | Upgrade |
Shares Change (YoY) | 2.52% | 11.46% | 3.48% | - | - | Upgrade |
EPS (Basic) | -0.14 | -0.08 | -0.10 | -0.03 | -0.02 | Upgrade |
EPS (Diluted) | -0.14 | -0.08 | -0.10 | -0.03 | -0.02 | Upgrade |
Free Cash Flow | - | -7.03 | -20.98 | 31.15 | -10.84 | Upgrade |
Free Cash Flow Per Share | - | -0.01 | -0.05 | 0.08 | -0.03 | Upgrade |
Gross Margin | 23.71% | 22.76% | 35.59% | 26.81% | 29.57% | Upgrade |
Operating Margin | -153.04% | -60.26% | -16.78% | -10.56% | -13.86% | Upgrade |
Profit Margin | -174.07% | -67.06% | -55.02% | -11.40% | -8.81% | Upgrade |
Free Cash Flow Margin | - | -11.72% | -27.46% | 29.10% | -12.34% | Upgrade |
EBITDA | -57.09 | -33.61 | -10.11 | -8.38 | -9.59 | Upgrade |
EBITDA Margin | -146.61% | -56.08% | -13.23% | -7.83% | -10.91% | Upgrade |
D&A For EBITDA | 2.5 | 2.5 | 2.72 | 2.92 | 2.59 | Upgrade |
EBIT | -59.6 | -36.11 | -12.82 | -11.3 | -12.18 | Upgrade |
EBIT Margin | -153.04% | -60.26% | -16.78% | -10.56% | -13.86% | Upgrade |
Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.